Has a ‘quademic’ hit the US? 4 viral infections and what to know about them
Four viruses are circulating in the U.S., sparking concerns of a possible “quademic." Here's what to know about risk factors ...
cidrap.umn5d
Real-world study: RSV vaccine 78% to 80% effective against infection, severe illness in older US veterans
The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...
What you need to know about the cases of HMPV infections
Human Metapneumovirus (HMPV) is a respiratory virus that can cause mild to severe respiratory issues. It spreads primarily ...
Becker's Hospital Review2d
RSV vaccine 78% effective against infection in veterans: 5 study notes
The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...
Symptoms of viral influenza, COVID-19, norovirus, and RSV can be signs of potential heart complications, warn experts
With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...
Too Old to Operate5d
Vaccination Reduces RSV Infection and Healthcare Visits in OAs
The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...
Managed Healthcare Executive7d
A Look at Human Metapneumovirus — a Respiratory Virus You've Likely Had Without Knowing
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Centre Daily Times3d
A highly contagious virus with no treatment is spreading in PA. How you can stay safe
Norovirus has no treatment and is highly contagious. It can linger on objects and surfaces for days or even weeks, as it’s resistant to most disinfectants and hand sanitizers, according to the ...
manilatimes1d
ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the ...
The Daily Star11d
Seasonal trends in respiratory infections: A global perspective
As winter takes hold in many parts of the world, there is a predictable rise in acute respiratory infections (ARIs). These increases are typically driven by seasonal epidemics of common pathogens ...